Co-Founder and Corporate Advisor
Cartherics Pty Ltd
Conference Day One: Tuesday, 9th April 2019
Tuesday, April 9th, 2019
11:30 AM CASE STUDY: Accelerating R&D in the Biopharmaceutical Industry through the Cooperative Research Centre - Project (CRC-P) scheme
The CRC-P scheme is designed to encourage collaboration between industry and academia on the achievement of three year, industry led projects. In 2017, Catherics Pty Ltd was the Lead Participant in a successful CRC-P application, receiving Commonwealth funding of almost $3M in support of a $12M project to develop allogeneic stem cell cancer immunotherapies. The other Participants in the CRC-P are Mesoblast Ltd, Cell Therapies Pty Ltd, Hudson Institute of Medical Research and Monash University. The project received ~$3 million from government funding, with ~$9 million being committed in cash and in kind contributions from the Participants over the three year project.
This session will describe how the CRC-P scheme encourages collaboration between universities and Industry, bringing them together to focus on an industry-led problem and drive research impact in the biopharmaceutical industry.
- Leveraging the CRC-P scheme to accelerate industry-led projects and build collaboration between industry and academia
- Overcoming cultural differences between key stakeholders to deliver impactful research
- Factors to measuring success to prove ROI to Government funding